Merck buys Bio‑Techne for €9.9bn to expand life‑science tools in cell and gene therapy Merck buys Bio‑Techne for €9.9bn, expanding life‑science tools for cell and gene therapy. Deal set to …
The Berlin Herald @2020 – All Right Reserved.